Respirology最新文献

筛选
英文 中文
Sensitive outcome measures to detect the association between PM2.5 and lung function impairment. 检测 PM2.5 与肺功能损伤之间关系的敏感结果测量。
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-10-16 DOI: 10.1111/resp.14844
Sanja Stanojevic
{"title":"Sensitive outcome measures to detect the association between PM<sub>2.5</sub> and lung function impairment.","authors":"Sanja Stanojevic","doi":"10.1111/resp.14844","DOIUrl":"10.1111/resp.14844","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1015-1016"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142473599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter from Indonesia. 来自印度尼西亚的信
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-08-08 DOI: 10.1111/resp.14814
Triya Damayanti, Ratnawati
{"title":"Letter from Indonesia.","authors":"Triya Damayanti, Ratnawati","doi":"10.1111/resp.14814","DOIUrl":"10.1111/resp.14814","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1105-1106"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer. 肺癌(基于互联网)德尔菲(LUCiD):修改后的 eDelphi 共识流程,用于制定澳大利亚胸腔癌临床质量指标。
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-08-13 DOI: 10.1111/resp.14812
Jessica Nash, Emily Stone, Shalini Vinod, Tracy Leong, Paul Dawkins, Rob G Stirling, Susan Harden, Alison Bolton, Annette McWilliams, Kenneth O'Byrne, Gavin M Wright, Vanessa N Brunelli, Tracey Guan, Shoni Philpot, Neal Navani, Fraser Brims
{"title":"Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer.","authors":"Jessica Nash, Emily Stone, Shalini Vinod, Tracy Leong, Paul Dawkins, Rob G Stirling, Susan Harden, Alison Bolton, Annette McWilliams, Kenneth O'Byrne, Gavin M Wright, Vanessa N Brunelli, Tracey Guan, Shoni Philpot, Neal Navani, Fraser Brims","doi":"10.1111/resp.14812","DOIUrl":"10.1111/resp.14812","url":null,"abstract":"<p><strong>Background and objective: </strong>Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand.</p><p><strong>Methods: </strong>Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting.</p><p><strong>Results: </strong>The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking.</p><p><strong>Conclusion: </strong>Twenty-seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1085-1094"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141976528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution. 肉样瘤病中的囊性肺:临床放射学特征和演变。
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-08-28 DOI: 10.1111/resp.14823
Giovanni Franco, Marie-Pierre Debray, Niccolò Anzani, Almerico Marruchella, Aurélie Cazes, Pierre Le Guen, Camille Taillé, Paola Faverio, Raphaël Borie, Fabrizio Luppi, Bruno Crestani
{"title":"Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution.","authors":"Giovanni Franco, Marie-Pierre Debray, Niccolò Anzani, Almerico Marruchella, Aurélie Cazes, Pierre Le Guen, Camille Taillé, Paola Faverio, Raphaël Borie, Fabrizio Luppi, Bruno Crestani","doi":"10.1111/resp.14823","DOIUrl":"10.1111/resp.14823","url":null,"abstract":"<p><strong>Background and objective: </strong>Sarcoidosis can manifest with atypical findings on chest computed tomography (CT). Cysts are a rare manifestation of lung sarcoidosis. The aim of the study was to describe a series of patients with cystic sarcoidosis and their clinical-radiological characteristics and progression.</p><p><strong>Methods: </strong>In this retrospective, bicentric study we recruited all patients affected by sarcoidosis with lung cystic lesions at chest CT. We collected clinical characteristics, pulmonary tests and tracked number, distribution and size of the cysts at diagnosis and at the last evaluation.</p><p><strong>Results: </strong>Twelve patients (6 males, median age 53 years) were identified (prevalence: 1.9%; 95% Confidence Interval: 0.8%-2.9%). All patients presented multiple cystic lesions (median number: 14 [range: 2-216]) with a bilateral distribution in 10/12, micronodules and nodules in 11/12 and fibrotic lesions in 4/12. Seven patients had normal lung function test, three had an obstructive syndrome, one had a restrictive syndrome and one had coexistence of both. During follow-up (median: 10 years [range 1-16 years]), an increase of the number of cysts was observed in four patients. At last evaluation, 3/12 patients experienced a decline of forced vital capacity >10% and 3/12 patients a decline of diffusing capacity for carbon monoxide (DLCO) >10%. A lower DLCO at diagnosis, and the presence of nodules or fibrotic lesions on CT were associated with an increase in the number of cysts.</p><p><strong>Conclusion: </strong>Cystic lung lesions are rare in patients with sarcoidosis and do not influence long term prognosis.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1067-1076"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142093718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cough suppression as a radical but effective therapeutic strategy. 止咳是一种根治但有效的治疗策略。
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-10-07 DOI: 10.1111/resp.14840
Philip Bardin
{"title":"Cough suppression as a radical but effective therapeutic strategy.","authors":"Philip Bardin","doi":"10.1111/resp.14840","DOIUrl":"10.1111/resp.14840","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1103-1104"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COPD: The forgotten cardiovascular risk. 慢性阻塞性肺病:被遗忘的心血管风险。
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-09-30 DOI: 10.1111/resp.14837
Belinda Cochrane
{"title":"COPD: The forgotten cardiovascular risk.","authors":"Belinda Cochrane","doi":"10.1111/resp.14837","DOIUrl":"10.1111/resp.14837","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1013-1014"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142352911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. 成人超敏性肺炎的诊断与治疗:澳大利亚和新西兰胸腔协会的立场声明。
IF 6.6 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-10-28 DOI: 10.1111/resp.14847
Hayley Barnes, Tamera J Corte, Gregory Keir, Yet H Khor, Sandhya Limaye, Jeremy P Wrobel, Elizabeth Veitch, John Harrington, Leona Dowman, Lutz Beckert, David Milne, Rebekah De Losa, Wendy A Cooper, Peter T Bell, Pradeep Balakrishnan, Lauren K Troy
{"title":"Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand.","authors":"Hayley Barnes, Tamera J Corte, Gregory Keir, Yet H Khor, Sandhya Limaye, Jeremy P Wrobel, Elizabeth Veitch, John Harrington, Leona Dowman, Lutz Beckert, David Milne, Rebekah De Losa, Wendy A Cooper, Peter T Bell, Pradeep Balakrishnan, Lauren K Troy","doi":"10.1111/resp.14847","DOIUrl":"10.1111/resp.14847","url":null,"abstract":"<p><p>Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) relating to specific occupational, environmental or medication exposures. Disease behaviour is influenced by the nature of exposure and the host response, with varying degrees of lung inflammation and fibrosis seen within individuals. The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology, prognosis and management implications. This Thoracic Society of Australia and New Zealand (TSANZ) position statement aims to provide an up-to-date summary of the evidence for clinicians relating to the diagnosis and management of HP in adults, in the Australian and New Zealand context. This document highlights recent relevant findings and gaps in the literature for which further research is required.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1023-1046"},"PeriodicalIF":6.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of opioids in late-stage COPD-Where are we now? 阿片类药物在慢性阻塞性肺病晚期的应用--我们现在在哪里?
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-10-07 DOI: 10.1111/resp.14839
Thomas J Altree, David C Currow
{"title":"The use of opioids in late-stage COPD-Where are we now?","authors":"Thomas J Altree, David C Currow","doi":"10.1111/resp.14839","DOIUrl":"10.1111/resp.14839","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1017-1019"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silicosis-Where to from here? 矽肺病--何去何从?
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-11-03 DOI: 10.1111/resp.14853
Hayley Barnes, Daniel C Chambers
{"title":"Silicosis-Where to from here?","authors":"Hayley Barnes, Daniel C Chambers","doi":"10.1111/resp.14853","DOIUrl":"10.1111/resp.14853","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1020-1022"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of home-based telerehabilitation-assisted inspiratory muscle training in patients with idiopathic pulmonary fibrosis: A randomized controlled trial. 家庭远程康复辅助吸气肌训练对特发性肺纤维化患者的影响:随机对照试验
IF 5.3 2区 医学
Respirology Pub Date : 2024-12-01 Epub Date: 2024-08-11 DOI: 10.1111/resp.14810
Rıdvan Aktan, Kemal Can Tertemiz, Salih Yiğit, Sevgi Özalevli, Aylin Ozgen Alpaydin, Eyüp Sabri Uçan
{"title":"Effects of home-based telerehabilitation-assisted inspiratory muscle training in patients with idiopathic pulmonary fibrosis: A randomized controlled trial.","authors":"Rıdvan Aktan, Kemal Can Tertemiz, Salih Yiğit, Sevgi Özalevli, Aylin Ozgen Alpaydin, Eyüp Sabri Uçan","doi":"10.1111/resp.14810","DOIUrl":"10.1111/resp.14810","url":null,"abstract":"<p><strong>Background and objective: </strong>There are few studies that have used inspiratory muscle training (IMT) as an intervention for patients with isolated idiopathic pulmonary fibrosis (IPF). This study aimed to investigate and interpret the effects of home-based telerehabilitation-assisted IMT in patients with IPF.</p><p><strong>Methods: </strong>Twenty-eight participants with IPF took part in the study. Lung function tests, functional exercise capacity by 6-min walk distance (6MWD), dyspnoea perception by modified medical research council dyspnoea scale (mMRC), and inspiratory muscle strength by maximal inspiratory pressure (MIP) were assessed. IMT was performed twice a day, 7 days/week, for 8 weeks. The intervention group (n = 14) performed IMT at 50% of their baseline MIP while the control group (n = 14) performed IMT without applied resistance. Loading intensity was progressed by keeping the load at 4-6 on a modified Borg scale for the highest tolerable perceived respiratory effort for each patient.</p><p><strong>Results: </strong>Dyspnoea based on mMRC score (p < 0.001, η<sup>2</sup> effect size = 0.48) significantly decreased within the intervention group compared with the control group. There were significant increases in the intervention group compared to the control group based on 6MWD (p < 0.001, η<sup>2</sup> effect size = 0.43), MIP (p = 0.006, η<sup>2</sup> effect size = 0.25) and MIP % predicted (p = 0.008, η<sup>2</sup> effect size = 0.25).</p><p><strong>Conclusion: </strong>The findings of this study suggest that an 8-week home-based telerehabilitation-assisted IMT intervention produced improvements in inspiratory muscle strength, leading to improvements in functional exercise capacity and dyspnoea.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"1077-1084"},"PeriodicalIF":5.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信